Prevalence and Factors Associated with Erectile Dysfunction in Diabetic Patients at the National University Hospital Center Hubert Koutoukou Maga in Cotonou
Erectile dysfunction was one of the most common complications in diabetic patients. According to several studies, its prevalence was two to three times higher in diabetics than in the general population. But it has often been overlooked despite the fact that it seriously affects the quality of life. The aim of this study was to determine the prevalence of erectile dysfunction and its associated factors in diabetics’ patients. This was a cross-sectional analysis study of 76 male diabetic patients who consulted by the Department of Endocrinology from June 22, 2019 to September 25, 2019. Erectile dysfunction was diagnosed by calculating the IIEF score. Statistical comparisons were made between patients without and with Erectile dysfunction chi-square test with a significance level p < 0.05. A logistic regression was performed in order to obtain the adjusted odds ratios. Our study included 76 patients with the mean age of 58.55 ± 10.5 years. 72.37% of them were over 50 years old. Erectile dysfunction screening was positive in 69.74%. HbA1c was ≥7% in 50 patients (65.79%). High blood pressure, imbalance in diabetes and its duration are factors that are significantly associated with Erectile dysfunction after logistic regression with p values equal to 0.011, respectively; 0.008 and <0.001. Conclusion: This study showed a high prevalence of erectile dysfunction in diabetics. Significant concomitant factors were hypertension, diabetes imbalance and the duration of diabetes. It was, therefore, important to include systematic screening for erectile dysfunction at least annually, as well as other complications of diabetes.
References
[1]
Yamasaki, H., Ogawa, K., Sasaki, H., Nakao, T., Wakasaki, H., Matsumoto, E., et al. (2004) Prevalence and Risk Factors of Erectile Dysfunction in Japanese Men with Type 2 Diabetes. Diabetes Research and Clinical Practice, 66, S173-S177. https://doi.org/10.1016/j.diabres.2003.09.019
[2]
Feldman, H.A., Goldstein, I., Hatzichristou, D.G., Krane, R.J. and McKinlay, J.B. (1994) Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study. The Journal of Urology, 151, 54-61. https://doi.org/10.1016/S0022-5347(17)34871-1
[3]
Whitehead, E.D. and Klyde, B.J. (1990) Diabetes-Related Impotence in the Elderly. Clinics in Geriatric Medicine, 6, 771-795. https://doi.org/10.1016/S0749-0690(18)30580-9
[4]
McCulloch, D.K., Campbell, I.W., Wu, F.C., Prescott, R.J. and Clarke, B.F. (1980) The Prevalence of Diabetic Impotence. Diabetologia, 18, 279-283. https://doi.org/10.1007/BF00251005
[5]
Delavierre, D. (2002) Epidémiologie de la dysfonction érectile (1ère partie). Prevalence et incidence mondiales. Andrologie, 12, 167-185. https://doi.org/10.1007/BF03034963
[6]
Lemaire, A. (2011) Diabète, endocrinopathies et érection. Médecine de la Reproduction, 13, 38-44.
[7]
Druet, C., Bourdel-Marchasson, I., Weill, A., Eschwege, E., Penfornis, A., Fosse-Edorh, S., et al. (2013) Le diabète de type 2 en France: Epidémiologie, évolution de la qualité de la prise en charge, poids social et économique. Entred 2007. La Presse Médicale, 42, 830-838. https://doi.org/10.1016/j.lpm.2013.02.312
[8]
Rajfer, J., Aronson, W.J., Bush, P.A., Dorey, F.J. and Ignarro, L.J. (1992) Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission. The New England Journal of Medicine, 326, 90-94. https://doi.org/10.1056/NEJM199201093260203
[9]
Seftel, A.D., Vaziri, N.D., Ni, Z., Razmjouei, K., Fogarty, J., Hampel, N., Polak, J., Wang, R.Z., Ferguson, K., Block, C. and Haas, C. (1997) Advanced Glycation End Products in Human Penis: Elevation in Diabetic Tissue, Site of Deposition, and Possible Effect through Inos or Enos. Urology, 50, 1016-1026. https://doi.org/10.1016/S0090-4295(97)00512-8
[10]
Bivalacqua, T.J., Hellstrom, W.J., Kadowitz, P.J. and Champion, H.C. (2001) Increased Expression of Arginase II in Human Diabetic Corpus Cavernosum: In Diabetic-Associated Erectile Dysfunction. Biochemical and Biophysical Research Communications, 283, 923-927. https://doi.org/10.1006/bbrc.2001.4874
[11]
Rosen, R., Riley, A., Wagner, A., et al. (1997) The International Index of Erectile Function (IIEF): A Multidmensional Scale for Assessment of Erectile Dysfunction. Urology, 49, 822-830. https://doi.org/10.1016/S0090-4295(97)00238-0
[12]
Wanvoegbè, F.A., Hodonou, F., Agbodandé, K.A., Amoussou-Guenou, D., Djotinkpon, F., Amoussou-Guenou Fnadi, A., et al. (2020) Dysfonction érectile chez les patients diabétiques dans la ville de Porto-Novo: Aspects épidémiologiques et cliniques. Médecine d’Afrique Noire, 6701, 19-26.
[13]
El Achhab, Y., Berraho, M., Benslimane, A., Chrit, M., El Hassani, H., Lyoussi, B., et al. (2008) Diabetes and Erectile Dysfunction in Morocco: Epidemiological Study among Outpatients. Eastern Mediterranean Health Journal, 14, 1090-1100.
[14]
Raharinavalona, S.A., Razanamparany, T., Raherison, R.E., Vololontiana, H.M.D., Rakotomalala, A.D.P. (2017) Dépistage et profil épidémio-clinique de dysfonction érectile chez les diabétiques de type 2 à Antananarivo, Madagascar. La Revue Médicale de Madagascar, 7, 1-4.
[15]
Sagna, Y., Guira, O., Yaméogo, N.V., Bagbila, A.P., Yanogo, D., Seghda, T.A.A., et al. (2014) Prévalence et facteurs associés à la dysfonction érectile chez le patient diabétique à Ouagadougou, Burkina Faso. Médecine des Maladies Métaboliques, 8, 539-543. https://doi.org/10.1016/S1957-2557(14)70878-8
[16]
Gueye, S.M., Diop, S.N., Fall, P.A., Dagadou, E.K., Abdallahi, O.C., Ba, M. and Mensah, A. (1999) Les dysfonctions érectiles chez le diabétique: Rôle des facteurs neurologiques. Andrologie, 9, 515-518. https://doi.org/10.1007/BF03034670
[17]
Baldé, N.M., Diallo, A.B., Baldé, M.C., Kaké, A., Diallo, M.M., Diallo, M.B. and Maugendre, D. (2006) Dysfonction érectile et diabète à Conakry (Guinée): Fréquence et profil clinique à partir de 187 observations. Annales d’Endocrinologie, 67, 338-342. https://doi.org/10.1016/S0003-4266(06)72608-7
[18]
Gueye, S.M., Diop, S.N., Ba, M., Dagadou, E.K., Fall, P.A., Sow, M.A. and Mensah, A. (1998) La dysérection chez le diabétique. Profil épidémiologique au Sénégal. Progrès en Urologie, 8, 377-381.
[19]
Siu, S.C., Lo, S.K., Wong, K.W., Lp, K.M. and Wong, Y.S. (2001) Prevalence of and Risk Factors for Erectile Dysfunction in Hong Kong Diabetic Patients. Diabetic Medicine: A Journal of the British Diabetic Association, 18, 732-738. https://doi.org/10.1046/j.0742-3071.2001.00557.x
[20]
Monabeka, H.G., Bouya, P.A., Odzebe, S.W., Nzaka Moukala, C.D., Elenga-Mbongo, C., Andzouana, N. and Mayanda-Ohouana, R. (2010) Aspects epidemiologique et clinique de la dysfonction érectile chez les sujets diabétiques à brazzaville. Annales De L’universite Marien Ngouabi, 11, 26-32.
[21]
Zakhama, W., Chaabouni, A., Rzouga, S., Chaieb, N., Majdoub, A,. Binous, M., et al. (2012) Dysfonction érectile et diabète: Fréquence et profil clinique à partir de 200 observations. Basic and Clinical Andrology, 22, 96-101. https://doi.org/10.1007/s12610-012-0170-7
[22]
Lyngdorf, P. and Hemmingsen, L. (2004) Epidemiology of Erectile Dysfunction and Its Risk Factors: A Practice-Based Study in Denmark. International Journal of Impotence Research, 16, 105-111. https://doi.org/10.1038/sj.ijir.3901184
[23]
Kalter-Leibovici, O., Wainstein, J., Ziv, A., Harman-Bohem, I., Murad, H., Raz, I., et al. (2005) Clinical, Socioeconomic, and Lifestyle Parameters Associated with Erectile Dysfunction among Diabetic Men. Diabetes Care, 28, 1739-1744. https://doi.org/10.2337/diacare.28.7.1739
[24]
Adebusoye, L.A., Olapade-Olaopa, O.E., Ladipo, M.M. and Owoaje, E.T. (2012) Prevalence and Correlates of Erectile Dysfunction among Primary Care Clinic Attendees in Nigeria. Global Journal of Health Science, 4, 107-117. https://doi.org/10.5539/gjhs.v4n4p107
[25]
Awad, H., Salem, A., Gadalla, A., El Wafa, N.A. and Mohamed, O.A. (2010) Erectile Function in Men with Diabetes Type 2: Correlation with Glycemic Control. International Journal of Impotence Research, 22, 36-39. https://doi.org/10.1038/ijir.2009.39
[26]
Ziaei-Rad, M., Vahdaninia, M. and Montazeri, A. (2010) Sexual Dysfunctions in Patients with Diabetes: A Study from Iran. Reproductive Biology and Endocrinology, 8, Article No. 50. https://doi.org/10.1186/1477-7827-8-50
[27]
Hatzimouratidis, K. and Hatzichristou, D. (2014) How to Treat Erectile Dysfunction in Men with Diabetes: From Pathophysiology to Treatment. Current Diabetes Reports, 14, Article No. 545. https://doi.org/10.1007/s11892-014-0545-6
